A vaccine designed to prevent and potentially treat triple-negative breast cancer is showing promise in human trials and ...

As confusion grows around COVID-19 access amid controversial moves by the CDC and FDA, states are taking matters into their ...

The at-home vaccine is the same as regular FluMist, which is approved for ages two through 49. That means babies and older ...

New guidelines limit shots to adults 65+ and those with underlying conditions, though Cleveland area pharmacies are making ...

Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly, STAT News ...

Six months after his abrupt resignation as CBER director, Marks has been hired to run discovery and infectious disease work ...

Dr. Paul Offit, a frequent critic of US Health and Human Services Secretary Robert F. Kennedy Jr., has been blocked from participating in a panel of independent experts who advise the US Food and Drug ...

If you have commercial insurance, you may be able to get FluMist delivered to your home. You may only need to pay an $8.99 ...

The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use ...

The Trump administration is pushing for single-virus shots for measles, mumps, and rubella. It's an anti-vaccine talking ...

GLSI-100 has received FDA fast track designation for HLA-A*02-positive and HER2-positive breast cancer, expediting its development and review process. Preliminary data from the FLAMINGO-01 trial shows ...

Dr. Peter Marks, the former head of vaccine regulation for the Food and Drug Administration, has been hired by pharmaceutical ...